Arcturus Therapeutics Statistics
NASDAQ: ARCTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
7.45-0.15 (-1.97%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Arcturus Therapeutics by the numbers
Arcturus Therapeutics has a market capitalization of $214.7 million based on 28.82M shares outstanding. With trailing EPS of $-3.10, Arcturus Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 36.4% below its 50-day average and 18.3% below its 200-day average.
Average daily trading volume is 851.45K shares, or about $6.3 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ARCT valuation vs. peer median
| Metric | ARCT | Peer median | Difference |
|---|---|---|---|
| Market cap | $214.73M | $216.96M | -1% |
| Avg. volume | 851.45K | 903.02K | -6% |
Peer median across 8 companies: PYXS, KROS, RCKT, IMRX, CYPH, VNDA, ENTA, FTH.
Valuation
- Market cap
- $214.73M
- Price / sales (latest FY)
- 2.62
- EPS (TTM)
- $-3.10
- Shares outstanding
- 28.82M
Price and trading
- Previous close
- 7.60
- Open
- 7.38
- Day range
- 7.31 – 7.73
- 52-week range
- 5.50 – 17.96
- 52-week change
- +19.01%
- Beta
- —
- Volume
- 601.93K
- Average volume
- 851.45K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 214.73M
- Forward Pe
- -2.18
- Eps
- -3.10
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 17.96
- Week52 Low
- 5.50
- Avg Volume
- 851.45K
- Shares Outstanding
- 28.82M
- Ma50
- 11.72
- Ma200
- 9.12
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -58.52%
- Pct From52w Low
- 35.45%